366 related articles for article (PubMed ID: 31137045)
1. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
Mosebach J; Thierjung H; Schlemmer HP; Delorme S
Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines.
Lee K; Kim KW; Ko Y; Park HY; Chae EJ; Lee JH; Ryu JS; Chung HW
Korean J Radiol; 2021 Sep; 22(9):1497-1513. PubMed ID: 34448381
[TBL] [Abstract][Full Text] [Related]
4. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Multiple Myeloma.
Kosmala A; Bley T; Petritsch B
Rofo; 2019 Sep; 191(9):805-816. PubMed ID: 31185511
[TBL] [Abstract][Full Text] [Related]
6. Updates and Ongoing Challenges in Imaging of Multiple Myeloma:
Wu F; Bernard S; Fayad LM; Ilaslan H; Messiou C; Moulopoulos LA; Mulligan ME
AJR Am J Roentgenol; 2021 Oct; 217(4):775-785. PubMed ID: 33978464
[TBL] [Abstract][Full Text] [Related]
7. The Critical Role of Imaging in the Management of Multiple Myeloma.
Raza S; Leng S; Lentzsch S
Curr Hematol Malig Rep; 2017 Jun; 12(3):168-175. PubMed ID: 28317080
[TBL] [Abstract][Full Text] [Related]
8. Imaging in myeloma with focus on advanced imaging techniques.
Barwick T; Bretsztajn L; Wallitt K; Amiras D; Rockall A; Messiou C
Br J Radiol; 2019 Mar; 92(1095):20180768. PubMed ID: 30604631
[TBL] [Abstract][Full Text] [Related]
9. [Multiple myeloma: current recommendations for imaging].
Hillengass J; Delorme S
Radiologe; 2012 Apr; 52(4):360-5. PubMed ID: 22441560
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the use of imaging in the management of patients with myeloma.
Chantry A; Kazmi M; Barrington S; Goh V; Mulholland N; Streetly M; Lai M; Pratt G;
Br J Haematol; 2017 Aug; 178(3):380-393. PubMed ID: 28677897
[TBL] [Abstract][Full Text] [Related]
12. How do we image patients with multiple myeloma and precursor states?
Chakraborty R; Hillengass J; Lentzsch S
Br J Haematol; 2023 Nov; 203(4):536-545. PubMed ID: 37217164
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
Mihailovic J; Goldsmith SJ
Semin Nucl Med; 2015 Jan; 45(1):16-31. PubMed ID: 25475376
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
15. Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.
Lecouvet FE; Vekemans MC; Van Den Berghe T; Verstraete K; Kirchgesner T; Acid S; Malghem J; Wuts J; Hillengass J; Vandecaveye V; Jamar F; Gheysens O; Vande Berg BC
Skeletal Radiol; 2022 Jan; 51(1):59-80. PubMed ID: 34363522
[TBL] [Abstract][Full Text] [Related]
16. (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.
Lin C; Ho CL; Ng SH; Wang PN; Huang Y; Lin YC; Tang TC; Tsai SF; Rahmouni A; Yen TC
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):41-9. PubMed ID: 24129710
[TBL] [Abstract][Full Text] [Related]
17. Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
Mesguich C; Hulin C; Latrabe V; Asselineau J; Bordenave L; Perez P; Hindie E; Marit G
JMIR Res Protoc; 2020 Sep; 9(9):e17850. PubMed ID: 32909953
[TBL] [Abstract][Full Text] [Related]
18. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
Terpos E; Dimopoulos MA; Moulopoulos LA
Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
[TBL] [Abstract][Full Text] [Related]
19. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
[TBL] [Abstract][Full Text] [Related]
20. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]